Practice Management

Top Story

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process
November 16, 2017

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.

“Ninety percent doesn’t sound so good if it’s you,” Gottlieb, now 44, told HemOnc Today following a keynote presentation at the Friends of Cancer Research Annual Meeting. “So, to me, that 10% sounded pretty grim.”

Meeting News

Technology, organization of effort crucial for disaster recovery

November 15, 2017
NEW ORLEANS — Ophthalmologists can play a key role in disaster recovery by mobilizing efforts, organizing aid and offering services to areas and citizens affected…
Meeting News

AMA adopts new strategy for genetic tests, therapeutics

November 15, 2017
AMA recently voted to advance the development of a comprehensive strategy that allows more consistent coverage of genomic and genetic tests and precision medicine, a…

Trump nominates former pharmaceutical executive for HHS secretary

November 13, 2017
President Donald J. Trump has nominated Alex Azar II, the head of pharmaceutical company Eli Lilly’s U.S.-based operations until this past January, to be his next…
More Headlines »
CME COPE

Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 1

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to…
More »
Video
Meeting News

VIDEO: Kiawah Eye helps take practice from 'good to great'

June 15, 2017
More »
Resource Centers
American Academy of Optometry

American Academy of Optometry

Video
Meeting News

VIDEO: WIO brings women academics, private practice ophthalmologists together

August 16, 2017
More »
Advertisement
Advertisement